Aktive substanser, der hæmmer CYP2C19 Aktive substanser, der hæmmer CYP2C19 kan øge plasmakoncentrationen af lansoprazol.
Active substances, which inhibit CYP2C19 Active substances, which inhibit CYP2C19 may increase the plasma concentration of lansoprazole.